Chemical activators of TAAR7F include a variety of biogenic amines and related compounds that are capable of binding to and activating this G-protein-coupled receptor. Trimethylamine, for instance, can engage directly with the ligand-binding domain of TAAR7F, leading to receptor activation. This activation can elicit a signaling cascade through G-proteins, culminating in enhanced neuronal responses. Similarly, Isoamylamine can bind to TAAR7F, prompting a conformational alteration that activates the receptor and subsequently activates downstream signaling pathways within neuronal cells. β-Phenylethylamine is another such activator that, upon binding to TAAR7F, can activate the receptor, which is known to influence neurotransmitter release by initiating intracellular signaling cascades.
Tyramine and Tryptamine are also capable of activating TAAR7F, with Tyramine interacting with the receptor to induce G-protein signaling that leads to neuronal activation, whereas Tryptamine binds and activates TAAR7F, which triggers signaling pathways affecting neuronal activity. 3-Iodothyronamine can activate TAAR7F through direct binding, leading to a series of signaling events that modify neuronal signaling. Octopamine and Cadaverine can activate TAAR7F as well; Octopamine does so by binding to the receptor and activating central nervous system signaling pathways, while Cadaverine activates the receptor and subsequent neural signaling processes. Histamine, by directly interacting with TAAR7F, initiates signal transduction pathways associated with neuronal excitation. Dopamine, another activator, binds to TAAR7F, resulting in receptor activation and influencing neurotransmission. Serotonin's role in activating TAAR7F involves receptor binding, which then activates downstream signaling pathways that modulate neuronal activity. Lastly, N-Methyltryptamine can activate TAAR7F by receptor engagement, initiating G-protein-coupled signal transduction that leads to changes in neuronal signaling function. Each of these chemicals can activate TAAR7F through direct interactions that lead to various intracellular responses specific to neural cells.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Cadaverine | 462-94-2 | sc-239454 | 10 ml | $212.00 | ||
Cadaverine binds to TAAR7F, causing receptor activation and subsequent signaling events within neural circuits. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $92.00 $277.00 $969.00 | 7 | |
Histamine can activate TAAR7F through direct receptor interaction, leading to signal transduction pathways associated with neuronal excitation. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can serve as a ligand for TAAR7F, and its binding results in receptor activation and downstream effects on neurotransmission. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $116.00 $183.00 | 15 | |
Serotonin activates TAAR7F by binding to it, leading to the activation of downstream signaling pathways that modulate neuronal activity. |